Advertisement
Advertisement
U.S. markets open in 9 hours 2 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Valeo Pharma Inc. (VPH.TO)

Toronto - Toronto Real Time Price. Currency in CAD
0.63000.0000 (0.00%)
At close: 02:57PM EST
Advertisement

Valeo Pharma Inc.

16667 Hymus Boulevard
Kirkland, QC H9H 4R9
Canada

https://www.valeopharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees100

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven Saviuk CAVice Chairman & CEO259.34kN/A1959
Mr. Luc Mainville M.B.A, M.B.A.Sr. VP & CFO283.6kN/A1964
Mr. Guy-Paul AllardVP of Legal Affairs & Corp. Sec.N/AN/AN/A
Mr. Frederic DumaisDirector of Communications & Investor RelationsN/AN/AN/A
Mr. Kyle SteigerSr. VP & Chief Commercial OfficerN/AN/AN/A
Mr. Jean Francois FournierHead of Ophthalmology Bus. UnitN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. Its product portfolio includes Enerzair Breezhaler, an LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, an LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, Idiopathic Parkinson's Disease (PD) as an add-on for patients on stable dose of Levodopa alone or in combination with other drugs; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma. In addition, it offers Hesperco, bioflavonoid antioxidant used for immune support; Ametop, for skin Anesthesia prior to venepuncture or venous cannulation; Benztropine, an VPI-Anticholinergic agent used for the treatment of PD; Ethacrynate Sodium, a loop diuretic for high blood pressure and associated swelling; and Amikacin, an injectable antibiotic. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.

Corporate Governance

Valeo Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement